How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients

Endocrine. 2023 Jun;80(3):491-499. doi: 10.1007/s12020-023-03352-4. Epub 2023 Mar 31.
No abstract available

Publication types

  • Review

MeSH terms

  • Acromegaly* / drug therapy
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Symporters*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents
  • Glucose
  • Symporters
  • Sodium